An interventional study of Standard of care and Biotin supplement in Severe Obesity and Metabolic Syndrome, sponsored by Assistance Publique - Hôpitaux de Paris. Terminated at 1 site in France. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-01-15.
Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Other
Bariatric surgery improves health outcomes with a maximal weight loss on average occurring 1 year after surgery but with dramatic between-subjects variability in weight loss (ranging from 20 to 160% excess weight loss) for reasons that remain to be elucidated.
The investigators hypothesize that targeting the 3 months pre-surgery period by a calibrated dietary intervention, with fiber enrichment and biotin, will improve gut microbiota richness and subsequently improve subjects' metabolic health that may optimize post bariatric surgery outcomes.
The study is designed as a pilot, comparative, randomized, open-label trial with 4 arms: standard of care, biotin only, fibers only, biotin + fibers.
This is a pilot open label study that aims to examine the efficacy of biotin supplementation with or without enriched soluble and insoluble fibers given during 3 months before the bariatric surgery, on gut microbiota composition and functional capacity to produce B vitamins (primary outcomes), compared to standard of care (e.g. patient preparation to bariatric surgery).
The study is a 4-arm clinical trial:
Arm 1: patients with usual follow-up (standard of care) receiving during 3 months before the surgery usual general dietary recommendations regarding balanced diet comprising legumes and fruits, meat or equivalent, dairy products and starch and bread Arm 2: Same usual general dietary recommendations PLUS Biotin 450 µg per day (1 capsule per day) during 3 months before the surgery.
Arm 3: Same usual general dietary recommendations PLUS 3 servings per day of PureLean® Fiber, a powdered blend of fibers and prebiotics, during 3 months before the surgery Arm 4: Same usual general dietary recommendations PLUS 3 servings per day of PureLean® Fiber and Biotin 450 µg per day (1 capsule per day), during 3 months before the surgery.
There will be two periods: period 1 during the 3 months before bariatric surgery and period 3 after bariatric surgery (usual standard of care follow-up). The 4 groups will be compared before bariatric surgery and up to 6 months afterward
Patients will receive a schedule of hospitalizations and visits before and after the surgery:
At each visit (V0, V1, V2 , V3 and V4), will be performed as part of research:
Patients will be called 3 times between V0 and V1 by dietician as part of research.
1,964 studies on the registry are indexed under Metabolic Syndrome; 330 are open to participants now.
This study's enrollment of 5 is below the median of 60 across 1,460 interventional studies indexed under Metabolic Syndrome.
Browse Metabolic Syndrome studies →Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients receiving antibiotics (ATB) at the selection time or within the 2 previous months.
(if agreeing to participate to the study, the patients will be proposed randomization 3 months after stopping ATB)
receiving during 3 months before the surgery usual general dietary recommendations regarding balanced diet comprising legumes and fruits, meat or equivalent, dairy products and starch and bread
Other: Standard of care
Patients will receive the same usual general dietary recommendations PLUS 1 capsule per day of Biotin 450 µg per day during 3 months before the surgery.
Other: Standard of care · Dietary Supplement: Biotin supplement
Patients will receive the same usual general dietary recommendations PLUS 3 servings per day of PureLean® Fiber, a powdered blend of fibers and prebiotics, during 3 months before the surgery
Other: Standard of care · Dietary Supplement: Fiber supplement
Patients will receive the same usual general dietary recommendations PLUS 3 servings per day of PureLean® Fiber and Biotin 450 µg per day (1 capsule per day), during 3 months before the surgery.
Other: Standard of care · Dietary Supplement: Biotin supplement · Dietary Supplement: Fiber supplement
Patients receiving during 3 months before the surgery usual general dietary recommendations regarding balanced diet comprising legumes and fruits, meat or equivalent, dairy products and starch and bread
1 capsule per day of Biotin 450µg during 3 months before the surgery.
3 servings per day of PureLean® Fiber, a powdered blend of fibers and prebiotics, during 3 months before the surgery
3-month variation of gut microbiota richness 3 months after the start of the different dietary interventions
Access to gut microbiota richness will be provided after gut microbiota sequencing (by INRAE) with the acquisition of a table comprising the number of genes as well as the record of bacterial genes implicated in synthesis and transport of biotin. Based on preclinical observation, it is expected that the arm 4 combining biotin and fibers will show the highest richness
Time frame: At the inclusion and 3 months after supplementation
Assess changes in body weight between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery.
Body Weight will be obtained at each visit between 8 and 10 am using standardized procedures: Body weight will be obtained with a scale (Seca GmbH \& Co., Hamburg, Germany) in kilograms
Time frame: At the inclusion, 3months after supplementation, 3, 6 and 12 months after surgery
Assess changes in BMI between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery
Height will be obtained with measuring scale rounded to the nearest 0.5 cm in centimeters Weight and height will be combined to report BMI in kg/m\^2
Time frame: At the inclusion, 3months after supplementation, 3, 6 and 12 months after surgery
Assess changes in waist circumference between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery
Twaist circumference will be measured in centimeters at the level of the iliac crest and hip circumference at the level of the symphysis-great trochanter to the nearest 1 cm.
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in fat mass between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery
For the measurement of fat mass (in kilograms and percentage of body weight), patients will undergo DEXA analysis, using the Hologic Inc. machine, QDR 4500W t using standard software (Hologic Inc., S/N 47168 VER. 11.2)
Time frame: At the inclusion, 3 month after supplementation, 3, 6 and 12 months after surgery
Assess changes in lean mass between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery
For the measurement of lean mass (in kilograms and percentage of body weight), patients will undergo DEXA analysis, using the Hologic Inc. machine, QDR 4500W t using standard software (Hologic Inc., S/N 47168 VER. 11.2)
Time frame: At the inclusion, 3 month after supplementation, 3, 6 and 12 months after surgery
Assess changes in visceral adipose tissue mass between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery
For the measurement of visceral adipose tissue mass (in kilograms and percentage of body weight), patients will undergo DEXA analysis, using the Hologic Inc. machine, QDR 4500W t using standard software (Hologic Inc., S/N 47168 VER. 11.2)
Time frame: At the inclusion, 3 month after supplementation, 3, 6 and 12 months after surgery
Assess changes in blood pressure between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery.
Blood pressure (Systolic and Diastolic) will be measured three times with a mercury sphygmomanometer in the right arm, with patients in a sitting position after five minutes of rest. The average of the three measurements will be considered for analysis
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in insulin resistance markers between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery.
To predict insulin resistance, homeostatic model assessment of insulin resistance (HOMA-IR) will be calculated according to the following formula: HOMA-IR = \[fasting insulin (mU/l) x fasting blood glucose (mmol/l)\]/22.5.
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in insulin sensitivity markers between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery
Quantitative insulin sensitivity check index (QUICKI) will be calculated according to the following formula: QUICKI= 1/\[log(fasting insulin) + log(fasting blood glucose)
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess change in Leptin between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery.
Leptin (ng/mL) will be measured according to standard protocols using human Leptin ELISA Kit (MyBioSource, Cod. MBS9425103)
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess change in Adiponectin between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery.
Adiponectin (µg/mL) will be measured according to standard protocols using human Adiponectin /Acrp30 Quantikine ELISA kit (DRP300, R\&D Systems)
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in glucose between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery
A fasting venous blood draw will be taken from a vein on the forearm to verify blood glucose (g/L) using commercial kits
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in lipid profile between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery
A fasting venous blood draw will be taken from a vein on the forearm to verify triglycerides ( g/L), total cholesterol (g/L), HDL- cholesterol(g/L), LDL- cholesterol (g/L), using commercial kits
Time frame: At the inclusion, 3months after supplementation, 3, 6 and 12 months after surgery
Assess changes in liver function between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery
A fasting venous blood draw will be taken from a vein on the forearm to verify alanine aminotransferase (ALT) (UI/L), aspartate aminotransferase (AST) (UI/L), gamma-glutamyl transferase (GGT) (UI/L), using commercial kits
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess change in inflammatory marker (C-reactive protein) between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery.
C-reactive protein (mg/l) will be measured by multiplex analysis
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in inflammatory markers (IL6, sCD14, IL1b, IL10, TNF-R) between the visit 3 months before surgery and the pre-surgery visit, the visit at 3 and 6 months after surgery.
IL6, sCD14, IL1b, IL10, TNF-R (pg/mL) will be measured by multiplex analysis
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in adipose tissue gene expression for biotin-dependent carboxylases and inflammatory genes
Adipose tissue aspiration (100 mg): measure for adipose cell size and gene expression study (5-carboxylase depending of biotin and inflammatory markers).
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in quality of life
Information regarding their usual lifestyle by autoquestionnaire: SF-36 (Medical Outcome Study Short Form - 36) ranging from 0 to 100. A low score reflects a perception of poor health, loss of function, presence of pain. A high score reflects a perception of good health, an absence of functional deficit and pain
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in emotional eating
Information regarding their usual lifestyle by autoquestionnaire : Dutch Eating Behaviour Questionaire ( DEBQ) : this questionnaire is composed by 33 items divided into 3 scores. Of the original 100 items, 33 will be maintained and divided into 3 scores. Each question allows for 5 possible answers rated from 0 to 5 points. The possible answers are: never (1 point), rarely (2 points), sometimes (3 points), often (4 points), very often (5 points). The scores are as follows: * Restriction score: 10 questions on the "organised" will to control one's weight. * Emotionality score: 13 questions divided into two sub-scores, diffuse emotionality for 4 questions and definite emotionality for 9 questions * Externality score: 10 questions For each score, if the average of the responses is higher than 30, the subject is considered respectively: restricted, emotional eating or external.
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in physical activity
Information regarding their usual lifestyle by autoquestionnaire : Recent Physical Activity Questionnaire ( RPAQ) : * Interpretation of the physical activity (PA) level : Total sum week + weekend : * \<8.3 MET.h/week: inactive ; * From 8.3 MET.h/week: active, with the possibility of two levels: * From 8.3 to 16.7: moderate PA; * \>16.7: high PA. * interpretation of the time spent inactive : For weekdays and weekends: * ≤7h/d: non-sedentary ; * \>7h/d: sedentary.
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in anxiety
Information regarding their usual lifestyle by autoquestionnaire : HAD questionnaire (Hospital Anxiety and Depression questionnaire) : the HAD scale is an instrument to screen for anxiety and depressive disorders. It consists of 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D). (total D), thus allowing two scores to be obtained (maximum score for each score = 21). For each of the scores (A and D): * 7 or less: no symptomatology * 8 to 10: doubtful symptomatology * 11 and more: definite symptomatology.
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in sleep quality
Information regarding their usual lifestyle by autoquestionnaire : STOP band (Snoring - Tired - Observed apnea - Pressure - BMI - Age - Neck size - Gender) questionnaire: Interpretation of the STOP-BANG: The STOP-BANG score can be used to identify subjects at risk of sleep apnea (S.A.). * Low risk of S.A.: Score from 0 to 2. * Moderate risk of S.A.: Score of 3 to 4. * High risk of S.A.: Score of 5 to 8, or STOP ≥ 2 and male sex, or STOP ≥ 2 and BMI \> 35, or STOP ≥ 2 and neck circumference \> 40cm.
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in stool consistency
Patients will be asked to answer a Bristol stool scale : the Bristol Scale has seven types of profiles, ranging from constipation (type 1 and 2) to diarrhea (type 6 and 7). Each type corresponds to a specific description of the stool.
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Assess changes in stool inflammatory markers
Fecal calprotectin (in µg/g of feces) will be measured through ELISA kit
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Change in gut microbiota composition by quantitative metagenomics.
Total fecal DNA will be extracted, sequenced by oxford nanopores technology and analysed using momr R package.
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Change in intestinal permeability by Zonuline dosage
Zonuline dosage (ng/mL)
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Change in intestinal permeability by LPS-binding protein dosage
LPS-binding protein dosage (mg/L)
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Systemic measurement of Biotin (B8),B6 and B9-vitamins
Biotin (B8),B6 and B9 (nmol/L) will be measured by Elisa dosage from blood samples
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Systemic measurement of B12-vitamin
B12 (pmol/L) will be measured by Elisa dosage from blood samples
Time frame: At the inclusion, 3 months after supplementation, 3, 6 and 12 months after surgery
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris